THE TALK: Breast Cancer, A Review of Data from the SABCS 2021 Virtual Meeting

home / the-talk / breast-cancer-a-review-of-data-from-the-sabcs-2021-virtual-meeting

Sara A. Hurvitz, MD; Aditya Bardia, MD, MPH; Patrick Neven, MD, PhD; and Kevin Kalinsky, MD, MS, review recent updates and data in breast cancer presented at the SABCS 2021 Virtual Meeting.

EP. 1: Coming Soon: THE TALK: Breast Cancer, A Review of Data from the SABCS 2021 Virtual Meeting

By Sara Hurvitz, MD, UCLA

December 20th 2021

EP. 2: SABCS 2021 Updates in ER+ Breast Cancer

By Sara A. Hurvitz, MD
Aditya Bardia, MD, MPH

January 31st 2022

Experts in the management of breast cancer review recent data on SERDs (selective estrogen receptor degraders) in ER+/HER2 advanced breast cancer presented at SABCS [San Antonio Breast Cancer Symposium] 2021.

EP. 3: SABCS 2021 Updates in CDK4/6 Inhibitors in Breast Cancer

By Sara A. Hurvitz, MD
Aditya Bardia, MD, MPH

February 7th 2022

Sara A. Hurvitz, MD; Aditya Bardia, MD, MPH; Patrick Neven, MD, PhD; and Kevin Kalinsky MD, MS, discuss SABCS 2021 updates on the use of CDK4/6 inhibitors in HR+/HER2 breast cancer.

EP. 4: SABCS 2021 Updates in Key Clinical Trials for Breast Cancer

By Sara A. Hurvitz, MD
Aditya Bardia, MD, MPH

February 14th 2022

Patrick Neven MD, PhD; Sara A. Hurvitz, MD; Kevin Kalinsky, MD, MS; and Aditya Bardia, MD, MPH, share insight on updates in key clinical trials and novel therapies in breast cancer presented at SABCS 2021.